bluuebunny/crossref_metadata_2025_split huggingface dataset:
Conservative oxygen therapy in critically ill and perioperative period of patients with sepsis-associated encephalopathy
Authors: Li Yun , Zhao Lina , Yu Yang , Zhang Kai , Jiang Yi , Wang Zhiwei , Xie Keliang , Yu Yonghao 
Published: October 2022

ObjectivesSepsis-associated encephalopathy (SAE) patients in the intensive care unit (ICU) and perioperative period are administrated supplemental oxygen. However, the correlation between oxygenation status with SAE and the target for oxygen therapy remains unclear. This study aimed to examine the relationship between oxygen therapy and SAE patients.MethodsPatients diagnosed with sepsis 3.0 in the intensive care unit (ICU) were enrolled. The data were collected from the Medical Information Mart for Intensive Care IV (MIMIC IV) database and the eICU Collaborative Research Database (eICU-CRD) database. The generalized additive models were adopted to estimate the oxygen therapy targets in SAE patients. The results were confirmed by multivariate Logistic, propensity score analysis, inversion probability-weighting, doubly robust model, and multivariate COX analyses. Survival was analyzed by the Kaplan-Meier method.ResultsA total of 10055 patients from eICU-CRD and 1685 from MIMIC IV were included. The incidence of SAE patients was 58.43%. The range of PaO2 (97-339) mmHg, PaO2/FiO2 (189-619), and SPO2≥93% may reduce the incidence of SAE, which were verified by multivariable Logistic regression, propensity score analysis, inversion probability-weighting, and doubly robust model estimation in MIMIC IV database and eICU database. The range of PaO2/FiO2 (189-619) and SPO2≥93% may reduce the hospital mortality of SAE were verified by multivariable COX regression.ConclusionsSAE patients in ICU, including perioperative period, require conservative oxygen therapy. We should maintain SPO2≥93%, PaO2 (97-339) mmHg and PaO2/FiO2 (189-619) in SAE patients.
Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
Authors: Yan Jipeng , Zhao Jin , Ning Xiaoxuan , Qin Yunlong , Xing Yan , Wang Yuwei , Jia Qing , Huang Boyong , Ma Rui , Lei Changhui , Zhou Meilan , Yu Zixian , Zhang Yumeng , Guo Wei-Feng , Sun Shiren 
Published: October 2022

BackgroundEmerging evidence revealed that gut microbial dysbiosis is implicated in the development of plasma cell dyscrasias and amyloid deposition diseases, but no data are available on the relationship between gut microbiota and immunoglobulin light chain (AL) amyloidosis.MethodsTo characterize the gut microbiota in patients with AL amyloidosis, we collected fecal samples from patients with AL amyloidosis (n=27) and age-, gender-, and BMI-matched healthy controls (n=27), and conducted 16S rRNA MiSeq sequencing and amplicon sequence variants (ASV)-based analysis.ResultsThere were significant differences in gut microbial communities between the two groups. At the phylum level, the abundance of Actinobacteriota and Verrucomicrobiota was significantly higher, while Bacteroidota reduced remarkably in patients with AL amyloidosis. At the genus level, 17 genera, including Bifidobacterium, Akkermansia, and Streptococcus were enriched, while only 4 genera including Faecalibacterium, Tyzzerella, Pseudomonas, and Anaerostignum decreased evidently in patients with AL amyloidosis. Notably, 5 optimal ASV-based microbial markers were identified as the diagnostic model of AL amyloidosis and the AUC value of the train set and the test set was 0.8549 (95% CI 0.7310-0.9789) and 0.8025 (95% CI 0.5771-1), respectively. With a median follow-up of 19.0 months, further subgroup analysis also demonstrated some key gut microbial markers were related to disease severity, treatment response, and even prognosis of patients with AL amyloidosis.ConclusionsFor the first time, we demonstrated the alterations of gut microbiota in AL amyloidosis and successfully established and validated the microbial-based diagnostic model, which boosted more studies about microbe-based strategies for diagnosis and treatment in patients with AL amyloidosis in the future.
Preparation of PCU/PPy composites with self-healing and UV shielding properties
Authors: Xiong Zhengrong , Zhang Hang , Zhou Yan , Yang Yuming 
Published: October 2022

Polycarbonate-based polyurethanes (PCU) are frequently used in airship envelope materials because of its outstanding mechanical performances and aging resistance. However, the surface of PCU is likely damaged during processing and operating and the emerged minuscule cracks will lead to deterioration of perfomances for airship’s envelope materials. Herein, self-healing PCU/polypyrrole nanoparticles (PPy) composites were prepared by solution blending and quick healing of specific area for PCU was realized due to the high photo-thermal conversion merit of PPy. The results show that, the mechanical properties of PCU/PPy composites can be restored to more than 80% and the gas barrier properties can also be basically repaired when irradiating the destroyed surface using near-infrared light for only 60s. In addition, the ultraviolet visible (UV-vis) shielding performance of the PCU/PPy composites was enhanced significantly and the UV-vis transmittance was less than 14% and 2% with 0.25wt% and 0.5wt% PPy, respectively. Meanwhile when 0.25wt% PPy was added, the tensile strength increased from 17.9MPa to 21.7 MPa and the elongation at break increased from 647% to 829%. Besides, the thermal decomposition temperature at 5wt% loss increased from 277.8°C to 300.7°C and 304.88°C with 0.25 wt% and 0.5 wt% PPy, respectively. The prepared composites show promising application in aerospace domain.
Stereopsis and visual acuity: Bilateral trifocal versus blended extended depth of focus and diffractive bifocal intraocular lenses
Authors: Zhu Meiyi , Fan Wei , Zhang Guangbin 
Published: October 2022

PurposeTo compare stereopsis and visual acuity (VA) between bilateral implantation of trifocal intraocular lenses (IOL) and blended implantation of an extended depth of focus (EDOF) IOL with a bifocal IOL.MethodsThis is a non-randomized, prospective comparative study included 74 eyes of 37 patients who underwent phacoemulsification and bilateral implantation of AT LISA tri 839MP IOL (bilateral group; 21 patients) or blended implantation of Tecnis Symfony ZXR00 and Tecnis ZLB00 IOL (blended group; 16 patients). The primary outcomes were stereoacuity and binocular VA. The secondary outcomes were visual defocus curve, quality of life, and patient satisfaction. Follow-up was performed 3 months after the surgery.ResultsThe mean near stereoacuity was 49.76 ± 22.67 and 120.63 ± 90.94 seconds of arc (arcsec) in the bilateral and blended groups, respectively (P &lt; 0.001). Near stereoacuity was positively correlated with VA difference of two eyes (r = 0.896, P &lt; 0.001). The mean binocular uncorrected visual acuity at 40 cm, 80 cm, 5 m, and corrected distance visual acuity at 5 m of the bilateral and blended groups was not statistically significant different. The bilateral group had better VA at a vergence from −2.5 to −4.0 D. Both groups obtained high quality of life and patient satisfaction scores.ConclusionThe bilateral and blended groups achieved good binocular VA, quality of life, and high patient satisfaction. However, the near stereoacuity of the blended group was worse.
Effect of keratometric astigmatism on visual outcomes following small incision lenticule extraction
Authors: Liu Shengtao , Yu Lanhui , Lu Zhiyuan , Cheng Chiwen , Gu Xuejun , Liu Jingying , Zhou Xingtao 
Published: October 2022

PurposeTo investigate the influence of keratometric astigmatism on visual outcomes following small incision lenticule extraction (SMILE).MethodsEighty eyes undergoing SMILE for myopia correction were classified into two groups based on preoperative keratometric astigmatism: low keratometric astigmatism (LA) and high keratometric astigmatism (HA) groups. Refractive outcomes, vector components, and changes in higher order aberrations (HOAs) were evaluated preoperatively and 6 months postoperatively.ResultsAt the postoperative 6-month visit, no significant difference was observed in the decentered distance between the HA and LA groups (HA: 0.17 ± 0.08 mm, LA: 0.16 ± 0.08 mm, P = 0.189). No significant differences in the correction index (P = 0.481), absolute angle of error (P = 0.104), or index of success (P = 0.147) were observed between the two groups. There was no significant difference in the induction of corneal aberrations between the two groups. Furthermore, there were no significant associations between the decentered distance and the vector components of astigmatic correction or induction of higher-order aberration in the HA group (P ≥ 0.294, P ≥ 0.112) or the LA group (P ≥ 0.323, P ≥ 0.080).ConclusionsSMILE for high keratometric astigmatism could achieve comparable treatment centration and visual quality to that of low keratometric astigmatism
Serum vitamin E level and functional prognosis after traumatic brain injury with intracranial injury: A multicenter prospective study
Authors: Park Gwan Jin , Ro Young Sun , Yoon Hanna , Lee Stephen Gyung Won , Jung Eujene , Moon Sung Bae , Kim Sang Chul , Shin Sang Do ,   Pan-Asia Trauma Outcomes Study for Traumatic Brain Injury (PATOS-TBI) research network
Published: October 2022

BackgroundTraumatic brain injury (TBI) is a major public health problem with high mortality and disability. Vitamin E, one of the antioxidants for treatment of TBI, has not been sufficiently evaluated for predicting prognosis of TBI. This study aimed to evaluate the prognostic value of vitamin E on functional outcomes of TBI patients with intracranial injury.MethodsA multi-center prospective cohort study was conducted in five university hospitals between 2018 and 2020. Adult TBI patients who visited the emergency department (ED) with intracranial hemorrhage or diffuse axonal injury confirmed by radiological examination were eligible. Serum vitamin E levels (mg/dL) were categorized into 4 groups: low (0.0–5.4), low-normal (5.5–10.9), high-normal (11.0–16.9), and high (17.0–). Study outcomes were set as 1- and 6-month disability (Glasgow outcome scale (GOS) 1–4). Multilevel logistic regression analysis was conducted to calculate the adjusted odds ratios (AORs) of vitamin E for related outcomes.ResultsAmong 550 eligible TBI patients with intracranial injury, the median (IQR) of serum vitamin E was 10.0 (8.0–12.3) mg/dL; 204/550 (37.1%) had 1-month disability and 197/544 (36.1%) had 6-month disability of GOS 1–4. Compared with the high-normal group, the odds of 1-month disability and 6-month disability increased in the low and low-normal group (AORs (95% CIs): 3.66 (1.62–8.27) and 2.60 (1.15–5.85) for the low group and 1.63 (1.08–2.48) and 1.60 (1.04–2.43) for the low-normal group, respectively).ConclusionLow serum vitamin E level was associated with poor prognosis at 1 and 6 months after TBI with intracranial injury.
Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults
Authors: Larsen Nicholas W. , Stiles Lauren E. , Shaik Ruba , Schneider Logan , Muppidi Srikanth , Tsui Cheuk To , Geng Linda N. , Bonilla Hector , Miglis Mitchell G. 
Published: October 2022

BackgroundAutonomic dysfunction is a known complication of post-acute sequelae of SARS-CoV-2 (PASC)/long COVID, however prevalence and severity are unknown.ObjectiveTo assess the frequency, severity, and risk factors of autonomic dysfunction in PASC, and to determine whether severity of acute SARS-CoV-2 infection is associated with severity of autonomic dysfunction.DesignCross-sectional online survey of adults with PASC recruited through long COVID support groups between October 2020 and August 2021.Participants2,413 adults ages 18–64 years with PASC including patients who had a confirmed positive test for COVID-19 (test-confirmed) and participants who were diagnosed with COVID-19 based on clinical symptoms alone.Main measuresThe main outcome measure was the Composite Autonomic Symptom 31 (COMPASS-31) total score, used to assess global autonomic dysfunction. Test-confirmed hospitalized vs. test-confirmed non-hospitalized participants were compared to determine if the severity of acute SARS-CoV-2 infection was associated with the severity autonomic dysfunction.Key resultsSixty-six percent of PASC patients had a COMPASS-31 score &gt;20, suggestive of moderate to severe autonomic dysfunction. COMPASS-31 scores did not differ between test-confirmed hospitalized and test-confirmed non-hospitalized participants [28.95 (15.62, 46.60) vs. 26.4 (13.75, 42.10); p = 0.06].ConclusionsEvidence of moderate to severe autonomic dysfunction was seen in 66% of PASC patients in our study, independent of hospitalization status, suggesting that autonomic dysfunction is highly prevalent in the PASC population and independent of the severity of acute COVID-19 illness.
CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas
Authors: Wang Bo , Wei Wei , Long Shengrong , Wang Lesheng , Yang Bin , Wu Du , Li Zhengwei , Li Zhiqiang , Arshad Muhammad , Li Xiang , Chen Jincao 
Published: October 2022

BackgroundGlioma is the most common primary tumor of the central nervous system (CNS). Centromere protein A (CENPA) plays an essential role in ensuring that mitosis proceeds normally. The effect of CENPA on glioma is rarely reported. However, the current study aims to explore whether aberrant CENPA expression promotes glioma progression and the potential mechanisms involved.MethodsThe GEPIA website, The Cancer Genome Atlas, and the Gene Expression Omnibus (GEO) were used to assess the expression of CENPA in glioma. The results were validated by real-time quantitative polymerase chain reaction and immunohistochemical staining of clinical samples. The relationship between the expression and prognostic value of the CENPA gene in glioma was investigated by Kaplan–Meier (KM) survival analysis with RNA-seq and clinical profiles downloaded from the Chinese Glioma Genome Atlas (CGGA) and UCSC Xena. The association between CENPA and clinical characteristics was also evaluated. Cell Counting Kit-8 (CCK8) assay, wound healing assay using two glioma cell lines, gene set enrichment analysis (GSEA), KEGG and gene ontology (GO) enrichment analysis, immune infiltration analysis, temozolomide (TMZ) sensitivity analysis, and single-cell sequence analysis were performed to explore the underlying mechanisms of high CENPA expression and its effect on glioma development. Finally, we performed a Cox analysis based on the expression of CENPA to predict patient prognosis.ResultsCENPA was significantly upregulated in glioma tissue samples and correlated with patient prognosis. Moreover, the downregulation of CENPA inhibited the migration and proliferation of glioma cells. In addition, the expression level of CENPA was significantly correlated with the grade, primary–recurrent–secondary (PRS) type, IDH mutation status, and 1p19q codeletion status. Furthermore, CENPA could serve as an independent prognostic factor for glioma that mainly interferes with the normal progression of mitosis and regulates the tumor immune microenvironment favoring glioma development.ConclusionCENPA may act as a prognostic factor in patients with glioma and provide a novel target for the treatment of gliomas.
The outcome of severely injured patients following traumatic brain injury is affected by gender—A retrospective, multicenter, matched-pair analysis utilizing data of the TraumaRegister DGU®
Authors: Mair Olivia , Greve Frederik , Lefering Rolf , Biberthaler Peter , Hanschen Marc ,   the TraumaRegister DGU
Published: October 2022

IntroductionTraumatic brain injury (TBI) causes a major health-concern globally. Gender-dependent differences in mortality outcome after TBI have been controversially discussed.Materials and methodsWe conducted a retrospective, multicenter, matched-pair analysis using data collected by the TraumaRegister DGU® of the German Trauma Society between 2009 and 2020. All patients after severe trauma with the leading injury of TBI (AIS ≥ 3), above 18 years of age were included. Thereby, 42,034 cases were identified. We used 12 different matching criteria to ensure highly accurate matching and were able to match 11,738 pairs of one female and one male patient.ResultsAverage age at injury was 67.5 ± 19.6 years in women and 66.7 ± 19.1 years in men. Mean Injury Severity Score (ISS) was 21.3 ± 8.1 in women and 21.6 ± 8.2 in men. While women were more likely to die within the first week after trauma, the mortality was significantly higher in men overall (30.8 vs. 29.2%, p &lt; 0.002). Women were less likely to suffer from multi organ failure (MOF) (27.5 vs. 33.0%) or sepsis (4.5 vs. 7.1%). When comparing younger (≤ 45-years) and older (&gt; 45 years) patients, overall mortality was lower in men (13.1% men vs. 13.4% women) in the younger age group, but in the older group mortality was lower in women (33.8% men vs. 31.8% women).DiscussionGender-specific differences in the clinical outcome of severely injured patients with leading TBI could be detected. While women are overall characterized by an advantage in survival, this feature is not equally reproducible in premenopausal women. Therefore, the exact pathophysiological reasons for the described survival advantages of women will have to be explored in further prospective clinical studies.
Small area disease mapping of cancer incidence in British Columbia using Bayesian spatial models and the smallareamapp R Package
Authors: Simkin Jonathan , Dummer Trevor J. B. , Erickson Anders C. , Otterstatter Michael C. , Woods Ryan R. , Ogilvie Gina 
Published: October 2022

IntroductionThere is an increasing interest in small area analyses in cancer surveillance; however, technical capacity is limited and accessible analytical approaches remain to be determined. This study demonstrates an accessible approach for small area cancer risk estimation using Bayesian hierarchical models and data visualization through the smallareamapp R package.Materials and methodsIncident lung (N = 26,448), female breast (N = 28,466), cervical (N = 1,478), and colorectal (N = 25,457) cancers diagnosed among British Columbia (BC) residents between 2011 and 2018 were obtained from the BC Cancer Registry. Indirect age-standardization was used to derive age-adjusted expected counts and standardized incidence ratios (SIRs) relative to provincial rates. Moran’s I was used to assess the strength and direction of spatial autocorrelation. A modified Besag, York and Mollie model (BYM2) was used for model incidence counts to calculate posterior median relative risks (RR) by Community Health Service Areas (CHSA; N = 218), adjusting for spatial dependencies. Integrated Nested Laplace Approximation (INLA) was used for Bayesian model implementation. Areas with exceedance probabilities (above a threshold RR = 1.1) greater or equal to 80% were considered to have an elevated risk. The posterior median and 95% credible intervals (CrI) for the spatially structured effect were reported. Predictive posterior checks were conducted through predictive integral transformation values and observed versus fitted values.ResultsThe proportion of variance in the RR explained by a spatial effect ranged from 4.4% (male colorectal) to 19.2% (female breast). Lung cancer showed the greatest number of CHSAs with elevated risk (Nwomen = 50/218, Nmen = 44/218), representing 2357 total excess cases. The largest lung cancer RRs were 1.67 (95% CrI = 1.06–2.50; exceedance probability = 96%; cases = 13) among women and 2.49 (95% CrI = 2.14–2.88; exceedance probability = 100%; cases = 174) among men. Areas with small population sizes and extreme SIRs were generally smoothed towards the null (RR = 1.0).DiscussionWe present a ready-to-use approach for small area cancer risk estimation and disease mapping using BYM2 and exceedance probabilities. We developed the smallareamapp R package, which provides a user-friendly interface through an R-Shiny application, for epidemiologists and surveillance experts to examine geographic variation in risk. These methods and tools can be used to estimate risk, generate hypotheses, and examine ecologic associations while adjusting for spatial dependency.
A new approach to delineating clinical target volume for radiotherapy of glioblastoma: A phase II trial
Authors: Huang Yong , Ding Haixia , Luo Min , Li Zhiqiang , Li Sirui , Xie Conghua , Zhong Yahua 
Published: October 2022

PurposeNo consensus has currently been reached regarding the optimal radiation volume for radiotherapy of glioblastoma. Here, we have proposed a new delineation approach to delineating clinical target volume based on the relationship between the growth patterns of glioblastoma and neural pathways. Its safety and efficacy were evaluated in a phase II clinical trial.MethodsA total of 69 patients with histologically confirmed glioblastoma were enrolled. All patients underwent tumor resection, followed by focal radiotherapy and concomitant temozolomide (TMZ), and then received six cycles of adjuvant TMZ. The gross tumor volume (GTV) was defined as the surgical resection cavity plus any residual enhancing tumor, on contrast enhanced T1-weighted MRI. The clinical target volume (CTV) was delineated through our new approach.ResultsThe median recurrence-free survival (RFS) and overall survival (OS) were 11.4 months and 18.2 months, which were better than the previous reports. Relapse was found in 47 patients, of whom 41 patients (87.2%) failed in central, two patients (4.3%) failed in field, and four patients (8.5%) failed in distance. No marginal recurrence was found. Our regimen showed a trend of lower rates of marginal recurrence, and the brain volume of high-dose radiation fields in our regimen was similar to that of EORTC (p = 0.257).ConclusionsWe have proposed a novel method for the delineation of clinical target volume by referencing the nerve fiber bundles for radiotherapy of glioblastoma. The results of the present phase II clinical trial suggest that this approach may be feasible and effective.